Gut Aging Program Linked to Increased Cancer Risk – Scientists Discover
The Gut’s Rapid Cell Turnover and the Accumulation of Epigenetic Changes
Table of Contents
The human gut exhibits the fastest cell turnover rate of any tissue in the body, constantly renewing its lining with cells produced by specialized stem cells. However, a new study reveals that these stem cells accumulate epigenetic changes over time, following a predictable pattern linked to aging and potentially colon cancer.
What are Epigenetic Changes?
Epigenetic changes are chemical modifications to DNA that alter gene expression without changing the underlying DNA sequence itself. These modifications act as “on” or “off” switches, controlling which genes are active and which are silenced. They are a natural part of progress and cellular function, but their accumulation can contribute to age-related diseases.
For example, epigenetic changes can influence how cells respond to stress, repair damage, or regulate inflammation. A study by the National Institutes of Health details the role of epigenetics in aging and disease (NIH Epigenetics Fact Sheet).
The ACCA Process and the Nature Aging Study
Researchers led by Professor Francesco Neri at the University of Turin in Italy identified a process they termed ACCA (Aging- and Colon Cancer-Associated) during their inquiry into gut stem cell aging. The study, published in Nature Aging on January 8, 2026, demonstrates that these epigenetic changes aren’t random but follow a distinct pattern.
The research team analyzed stem cells from both young and old mice, observing a consistent shift in epigenetic markers with age. This shift correlated with a decline in the stem cells’ ability to regenerate the gut lining effectively. The full study is available through Nature Aging.
Implications for Colon Cancer
The ACCA process is not merely a outcome of aging; it also appears to be linked to the development of colon cancer. The researchers found that the same epigenetic changes observed in aging gut stem cells where also present in stem cells from colon cancer tumors.
according to the American Cancer Society, colon cancer is the third leading cause of cancer-related deaths in the United States. (American Cancer Society Key Statistics).Understanding the epigenetic mechanisms driving this disease could lead to new preventative strategies and treatments. The National cancer Institute provides detailed information on colon cancer research (NCI Colorectal Cancer).
Future Research Directions
Professor Neri’s team plans to investigate whether interventions targeting these epigenetic changes can restore the regenerative capacity of gut stem cells and potentially reduce the risk of colon cancer. Further research will focus on identifying specific enzymes and molecules involved in the ACCA process, paving the way for targeted therapies.